After obtaining clearance for emergency use in the UK and Bahrain, Pfizer Inc has applied for emergency use authorization in India. The UK is preparing for the emergency launches of the Pfizer vaccine and is now in the final planning stages before the vaccination campaign begins on December 14. In …
Read More »Serum Institute Requests Emergency Use Authorization for Oxford Covid-19 Covishield Vaccine in India | India News
NEW DELHI: The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the citing unmet medical needs due to the pandemic and in the …
Read More »Fortune or foresight? AstraZeneca and Oxford stories collide over covid-19 vaccine
The discrepancy, first reported by Reuters, centers on the regimen given to a smaller group of volunteers in late-stage trials, half a dose followed by a full dose. This differed from the original plan of two full doses, given to most of the participants. Also read | Inside the race …
Read More »Coronavirus Vaccine, Pfizer Covid Vaccine Never Applied For India’s Test Permission, Sources Say
The Covid pandemic has affected more than 6.38 million people worldwide (Representative) Highlight The Pfizer vaccine has been approved by the UK and will be launched soon For the vaccine to be allowed in India, you need to pass the clinical trials here Pfizer or its associated companies have not …
Read More »As the race for the virus vaccine heats up, IBS’s smear against the volunteer who brought the case worries experts
The Serum Institute of India has called the accusations made by a volunteer of the IBS vaccine candidate “malicious”. On November 21, a 40-year-old Chennai volunteer from vaccine candidate Covishield filed a lawsuit against IBS. The volunteer stated that there was no adverse reaction during the first 10 days after …
Read More »PM Modi visits vaccine plants in 3 cities, reviews progress | India News
PUNE / AHMEDABAD / HYDERABAD: Prime Minister Narendra Modi visited units of three vaccine Indian manufacturers to review the progress of the vaccine development and manufacturing process – Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India (SII) in Pune. Modi’s first stop was Ahmedabad, …
Read More »PM Modi reviews vaccine work in Ahmedabad, Hyderabad and Pune | India News
AHMEDABAD / HYDERABAD / PUNE: Prime Minister Narendra Modi visited Ahmedabad, Hyderabad and Pune on Saturday to review the coronavirus vaccine development work there. The Prime Minister’s Office (PMO) said the one-day visit was aimed at gaining a first-hand perspective of the preparations, challenges and roadmap in India’s effort to …
Read More »PM Modi will visit the vaccine manufacturing units in Ahmedabad, Hyderabad, Pune today | India News
NEW DELHI: Prime Minister Narendra Modi will embark on a three-city visit on Saturday to personally review the vaccine development and manufacturing process. He will visit the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and the Serum Institute of India in Pune, Maharashtra, the Prime Minister’s Office said. …
Read More »’10 Covid-19 vaccines could be available by mid-2021 ‘: global pharmaceutical group
Ten Covid-19 vaccines could be available by the middle of next year if they get regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday. Vaccines from Pfizer and BioNtech, as well as Moderna and AstraZeneca, have shown promising results in …
Read More »Ten Covid-19 Vaccines Seen Mid-Year, Says Global Pharma Group Head
GENEVA: Ten Covid-19 vaccines could be available by the middle of next year if they get regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday. Vaccines from Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results …
Read More »